Table 2 Patient characteristics and stroke treatments for 2019 and 2021 (Data from the Destatis database)

IS, n

225,531

217,002

 Age (mean ± SD)*

74.2 ± 4.9

74.2 ± 4.8

T test

p = 1.000

 Sex, male, n (%)*

118,755 (52.7%)

115,648 (53.3%)

χ² test

p < 0.001

 ≥ 80 years, n (%)*

88,332 (39.2%)

88,066 (40.6%)

χ² test

p < 0.001

IVT rate, n (%)

37,009 (16.4%)

35,831 (16.5%)

χ² test

p = 0.360

 Age (mean ± SD)**

73.6 ± 4.6

73.5 ± 4.6

T test

p = 0.003

 Sex, male, n (%)**

19,442 (52.5%)

19,076 (53.2%)

χ² test

p = 0.056

 ≥ 80 years, n (%)**

14,062 (38.0%)

14,023 (39.1%)

χ² test

p = 0.002

MTE rate, n (%)

16,135 (7.1%)

18,255 (8.4%)

χ² test

p < 0.001

 Age (mean ± SD)***

74.3 ± 5.0

74.4 ± 4.9

T test

p = 0.060

 Sex, male, n (%)***

7331 (45.4%)

8497 (46.5%)

χ² test

p = 0.039

  ≥ 80 years, n (%)***

6486 (40.2%)

7668 (42.0%)

χ² test

p < 0.001

 Number of regions with MTE rates ≤ 4.1%, n (%)

49 (12.3%)

21 (5.3%)

χ² test

p < 0.001